Enliven Therapeutics, Inc. financial data

Symbol
ELVN on Nasdaq
Industry
Pharmaceutical Preparations
Location
6200 Lookout Road, Boulder, CO
State of incorporation
DE
Fiscal year end
December 31
Former names
IMARA Inc. (to 2/23/2023)
Latest financial report
10-Q - Q3 2024 - Nov 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.35K % -38.9%
Debt-to-equity 7.79 % +35%
Return On Equity -29.5 % +9.94%
Return On Assets -27.3 % -4.95%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 48.9M shares +18.6%
Common Stock, Shares, Outstanding 47.3M shares +14.7%
Entity Public Float 382M USD +1736%
Common Stock, Value, Issued 47K USD +14.6%
Weighted Average Number of Shares Outstanding, Basic 48.3M shares +17.6%
Weighted Average Number of Shares Outstanding, Diluted 48.3M shares +17.6%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 78M USD +42.1%
General and Administrative Expense 22.4M USD +39.3%
Operating Income (Loss) -100M USD -41.5%
Nonoperating Income (Expense) 15.2M USD +64.9%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -85.2M USD -38%
Earnings Per Share, Basic -1.72 USD/shares +62.9%
Earnings Per Share, Diluted -1.72 USD/shares +62.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 101M USD +36.3%
Marketable Securities, Current 191M USD +0.83%
Cash, Cash Equivalents, and Short-term Investments 292M USD +10.7%
Assets, Current 297M USD +10.6%
Property, Plant and Equipment, Net 549K USD -31.9%
Operating Lease, Right-of-Use Asset 81K USD -79.6%
Other Assets, Noncurrent 7.24M USD +100%
Assets 305M USD +11.5%
Accounts Payable, Current 1.02M USD -31.7%
Accrued Liabilities, Current 1.68M USD -63.5%
Liabilities, Current 17M USD +41%
Operating Lease, Liability, Noncurrent 0 USD -100%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 17M USD +38.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax 242K USD
Retained Earnings (Accumulated Deficit) -220M USD -63.1%
Stockholders' Equity Attributable to Parent 288M USD +10.2%
Liabilities and Equity 305M USD +11.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -23.4M USD -12.1%
Net Cash Provided by (Used in) Financing Activities 90.3M USD -62%
Net Cash Provided by (Used in) Investing Activities -17.9M USD -57594%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 47.3M shares +14.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 101M USD +36.2%
Deferred Tax Assets, Valuation Allowance 42.8M USD +119%
Deferred Tax Assets, Gross 42.9M USD +117%
Operating Lease, Liability 85K USD -79.4%
Depreciation 79K USD +17.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -84.8M USD -51.7%
Lessee, Operating Lease, Liability, to be Paid 85K USD -79.9%
Property, Plant and Equipment, Gross 1.46M USD +4.15%
Operating Lease, Liability, Current 85K USD -74.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 341K USD +20.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 341K USD +3.65%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year Three 647K USD +183%
Deferred Tax Assets, Operating Loss Carryforwards 19.7M USD +53.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 32.1M USD +19500%
Lessee, Operating Lease, Liability, to be Paid, Year Four 660K USD
Operating Lease, Payments 69K USD +1.47%
Additional Paid in Capital 508M USD +28.1%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 318K USD +1.27%
Deferred Tax Assets, Net of Valuation Allowance 19.8M USD +105%
Share-based Payment Arrangement, Expense 17.9M USD +68.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%